Edition:
United Kingdom

Anavex Life Sciences Corp (AVXL.OQ)

AVXL.OQ on NASDAQ Stock Exchange Capital Market

3.47USD
17 May 2019
Change (% chg)

$0.02 (+0.58%)
Prev Close
$3.45
Open
$3.42
Day's High
$3.48
Day's Low
$3.42
Volume
14,828
Avg. Vol
51,601
52-wk High
$4.35
52-wk Low
$1.25

About

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to treat Alzheimer's disease (AD), other central nervous system (CNS) diseases, pain... (more)

Overall

Beta: 2.41
Market Cap(Mil.): $170.43
Shares Outstanding(Mil.): 49.12
Dividend: --
Yield (%): --

Financials

  AVXL.OQ Industry Sector
P/E (TTM): -- 101.85 55.51
EPS (TTM): -0.52 -- --
ROI: -130.85 7.41 11.59
ROE: -130.85 7.88 16.33

Earnings vs. Estimates